Cullinan Oncology LLC
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 14 | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -7.7% | – | – | – | +555.6% | +22.0% | +12.5% | -1.2% | -3.7% | -1.3% | +1.3% | -1.3% | +1.3% | -1.3% | +1.3% | – | – | +0.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | +36.9% | -27.9% | +9.8% | +199.4% | -20.7% | +67.7% | -25.3% | -5.1% | +7.7% | +64.7% | +17.5% | +7.6% | -25.5% | +8.3% | +144.3% | -47.4% | +23.5% | +3.0% | -12.1% | +18.3% | -2.1% | +14.0% | +2.4% | +47.2% | -31.2% | +2.3% | -1.9% | +5.5% | – | |
| – | +487.5% | -80.9% | +55.6% | -21.4% | +218.2% | +120.0% | -63.3% | -23.5% | +221.4% | +1,644.4% | +0.0% | +21.7% | -20.3% | +16.2% | +18.9% | -2.5% | +690.9% | -58.9% | -6.4% | +18.0% | +136.5% | -39.7% | +31.7% | -5.7% | +11.9% | -5.6% | -4.2% | +7.5% | -3.1% | +16.0% | +11.5% | -3.0% | +9.0% | -7.0% | +9.1% | -7.7% | -9.6% | -6.0% | +10.7% | – | |
| – | – | – | – | – | +128.7% | +68.8% | -63.7% | -23.5% | +221.4% | +7,330.3% | +0.0% | +34.4% | -28.4% | +11.3% | +154.9% | -18.6% | +153.7% | -39.8% | -5.5% | +10.7% | +86.9% | -4.9% | -833.9% | – | +9.5% | +92.5% | -40.1% | +20.3% | +0.4% | -5.5% | +16.4% | -2.2% | +12.7% | -0.1% | +37.8% | -26.7% | -0.6% | -2.8% | +6.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,310.2% | – | – | – | – | -112.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -34.9% | -24.8% | -57.3% | -38.0% | +253.1% | -31.8% | +16.1% | +43.8% | +253.8% | +237.6% | +38.0% | +42.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,258.5% | – | – | – | – | -111.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -79.3% | -168.5% | – | – | -8,874.9% | – | -103.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -114.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,284.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.